
Reset all filters
01 6TAKEDA PHARMS USA
Reset all filters
01 27361676
02 28372872
03 29107912
Reset all filters
01 6Blank
Reset all filters
01 2Y
02 4Blank
Reset all filters
01 22024-03-08
02 42031-09-08
Patent Expiration Date : 2031-09-08
US Patent Number : 8372872
Drug Substance Claim :
Drug Product Claim :
Application Number : 21856
Patent Use Code : U-1346
Delist Requested :
Patent Use Description : USE OF FEBUXOSTAT FOR ...
Patent Expiration Date : 2031-09-08
Patent Expiration Date : 2031-09-08
US Patent Number : 9107912
Drug Substance Claim :
Drug Product Claim :
Application Number : 21856
Patent Use Code : U-1346
Delist Requested :
Patent Use Description : USE OF FEBUXOSTAT FOR ...
Patent Expiration Date : 2031-09-08
Patent Expiration Date : 2031-09-08
US Patent Number : 8372872
Drug Substance Claim :
Drug Product Claim :
Application Number : 21856
Patent Use Code : U-1346
Delist Requested :
Patent Use Description : USE OF FEBUXOSTAT FOR ...
Patent Expiration Date : 2031-09-08
Patent Expiration Date : 2031-09-08
US Patent Number : 9107912
Drug Substance Claim :
Drug Product Claim :
Application Number : 21856
Patent Use Code : U-1346
Delist Requested :
Patent Use Description : USE OF FEBUXOSTAT FOR ...
Patent Expiration Date : 2031-09-08
Patent Expiration Date : 2024-03-08
US Patent Number : 7361676
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21856
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-03-08
Patent Expiration Date : 2024-03-08
US Patent Number : 7361676
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21856
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-03-08